In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Abstracts include pivotal efficacy and safety data for CSL Behring's long-acting recombinant albumin fusion protein for hemophilia B; CSL Behring's recombinant coagulation factor development program reinforces the company's promise to develop specialty biotherapies that help people with serious medical conditions live full lives
Enterprise Applications Run with Unmatched Levels of Integrity and Control Using a Cryptographic Chain of Trust from the Application Layer to the Hardware